Frontiers in Immunology | Multiple Sclerosis and Neuroimmunology

Original Research

Published on 03 Mar 2025

The nomogram model predicts relapse risk in myelin oligodendrocyte glycoprotein antibody-associated disease: a single-center study

in Multiple Sclerosis and Neuroimmunology

Jiafei Cheng
Zhuoran Wang
Jing Wang
Xiaomin Pang
Jianli Wang
Meini Zhang
Junhong Guo
Huaxing Meng

Frontiers in Immunology

doi 10.3389/fimmu.2025.1527057

242 views

Review

Published on 28 Feb 2025

Digital remote monitoring of people with multiple sclerosis

in Multiple Sclerosis and Neuroimmunology

Michelangelo Dini
Giancarlo Comi
Letizia Leocani

Frontiers in Immunology

doi 10.3389/fimmu.2025.1514813

289 views

Original Research

Published on 27 Feb 2025

The gut-brain-axis one year after treatment with cladribine tablets in patients with relapsing remitting multiple sclerosis: a pilot study

in Multiple Sclerosis and Neuroimmunology

Jeske van Pamelen
Carla Rodriguez-Mogeda
Lynn van Olst
Susanne M. A. van der Pol
Maarten L. Boon
Janet de Beukelaar
Oliver H. H. Gerlach
Andries E. Budding
Joep Killestein
Helga E. de Vries

Frontiers in Immunology

doi 10.3389/fimmu.2025.1514762

331 views

Review

Accepted on 25 Feb 2025

Current Challenges in Secondary Progressive Multiple Sclerosis: Diagnosis, Activity Detection and Treatment

in Multiple Sclerosis and Neuroimmunology

Luis Brieva
Carmen Calles
Lamberto Landete Pascual
Celia Oreja-Guevara

Frontiers in Immunology

doi 10.3389/fimmu.2025.1543649

Case Report

Published on 25 Feb 2025

Case Report: Long-term suppression of relapses by dimethyl fumarate in a relapsing pediatric patient with myelin oligodendrocyte glycoprotein antibody–associated disease manifesting as acute disseminated encephalomyelitis, unilateral optic neuritis, and seizure episodes

in Multiple Sclerosis and Neuroimmunology

Masayuki Tahara
Tomonari Awaya
Keisuke Saito
Hideyuki Sawada

Frontiers in Immunology

doi 10.3389/fimmu.2025.1551379

298 views

Correction

Accepted on 24 Feb 2025

Corrigendum: Blood biomarker dynamics in people with relapsing multiple sclerosis treated with cladribine tablets: results of the 2-year MAGNIFY-MS study

in Multiple Sclerosis and Neuroimmunology

Heinz Wiendl
Frederik Barkhof
Xavier Montalban
Anat Achiron
Tobias Derfuss
Andrew Chan
Suzanne Hodgkinson
Alexandre Prat
Letizia Leocani
Klaus Schmierer

Frontiers in Immunology

doi 10.3389/fimmu.2025.1571978

Original Research

Accepted on 24 Feb 2025

Comparison of clinical and laboratory characteristics of neuromyelitis optica spectrum disorder with or without cerebrospinal fluid oligoclonal bands: a cohort with 36-month follow-up

in Multiple Sclerosis and Neuroimmunology

Wenbo Yang
Xiaoni Liu
Jie Wei
Yu Hai
Wanqing Wu
Jingguo Wang
Bo Deng
Xiaoqin Wu
Xiangjun Chen
Xiang Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1536853

Case Report

Published on 24 Feb 2025

Case Report: MOGAD - a steroid-responsive autoimmune meningoencephalitis mimicking infection

in Multiple Sclerosis and Neuroimmunology

Yihui Goh
Priscillia Pei Shi Lye
Paul Anantharajah Tambyah
Derek Tuck Loong Soon
Nares Smitasin
Jonathan Jia Yuan Ong
Clement Hsiang Rong Yong
Yee Cheun Chan
David Tang
Kay Wei Ping Ng

Frontiers in Immunology

doi 10.3389/fimmu.2025.1516178

565 views

Original Research

Published on 24 Feb 2025

The changes of NLRs family members in the brain of AD mouse model and AD patients

in Multiple Sclerosis and Neuroimmunology

Zehan Li
Yanling He
Jingdan Zhang
Jing Yang
Jinbo Cheng
Xuewu Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1555124

212 views

Case Report

Accepted on 21 Feb 2025

CASPR2-Associated Autoimmune Encephalitis with NF155 Antibody-Positive Autoimmune Nodopathies: A Rare Case with Hyponatremia Onset

in Multiple Sclerosis and Neuroimmunology

Wen-Ya Wang
Jing-Ying Huang
Ying Xue
An-Ran Zhang
Ruo-Yi Guo
Zhen Jia
Ya-Fei Sun
Bin Li

Frontiers in Immunology

doi 10.3389/fimmu.2025.1519878

Review

Published on 21 Feb 2025

Unraveling the immune system’s role in peripheral nerve regeneration: a pathway to enhanced healing

in Multiple Sclerosis and Neuroimmunology

Xu Zhang
Yanxian Zhang
Yuqing Chen
Yuxiang Ji
Yongmei Lyu
Zengli Miao
Xuchu Duan
Xiaoyu Liu

Frontiers in Immunology

doi 10.3389/fimmu.2025.1540199

361 views

Case Report

Accepted on 20 Feb 2025

Ofatumumab treatment for concomitant multiple sclerosis and idiopathic thrombocytopenic purpura

in Multiple Sclerosis and Neuroimmunology

Yuki Yokota
Makoto Hara
Hideto Nakajima

Frontiers in Immunology

doi 10.3389/fimmu.2025.1515776

115 views

Original Research

Published on 20 Feb 2025

Super-resolution of nodal and paranodal disruption in anti-pan-neurofascin-associated autoimmune nodopathy

in Multiple Sclerosis and Neuroimmunology

Vinicius da Cruz Neris Geßner
Janis Theobald Linke
Thomas-Otavio Peulen
Luise Appeltshauser
Claudia Sommer
Dirk Brämer
Christian Geis
Katrin Gertrud Heinze
Kathrin Doppler

Frontiers in Immunology

doi 10.3389/fimmu.2025.1540859

417 views

Case Report

Published on 18 Feb 2025

Case report: Plasma exchange as a therapy for Miller-Fisher syndrome

in Multiple Sclerosis and Neuroimmunology

Dongmei Guan
Yuanzhuang Shan
Hailin Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1460034

237 views

Perspective

Published on 17 Feb 2025

Artificial intelligence and science of patient input: a perspective from people with multiple sclerosis

in Multiple Sclerosis and Neuroimmunology

Anne Helme
Dipak Kalra
Giampaolo Brichetto
Guy Peryer
Patrick Vermersch
Helga Weiland
Angela White
Paola Zaratin

Frontiers in Immunology

doi 10.3389/fimmu.2025.1487709

269 views

Review

Published on 17 Feb 2025

Sexual dimorphism in immunity and longevity among the oldest old

in Multiple Sclerosis and Neuroimmunology

Nelli A. Arakelyan
Daria A. Kupriyanova
Jelena Vasilevska
Evgeny I. Rogaev

Frontiers in Immunology

doi 10.3389/fimmu.2025.1525948

329 views

Navigation group

Articles

The nomogram model predicts relapse risk in myelin oligodendrocyte glycoprotein antibody-associated disease: a single-center study

Digital remote monitoring of people with multiple sclerosis

The gut-brain-axis one year after treatment with cladribine tablets in patients with relapsing remitting multiple sclerosis: a pilot study

Current Challenges in Secondary Progressive Multiple Sclerosis: Diagnosis, Activity Detection and Treatment

Case Report: Long-term suppression of relapses by dimethyl fumarate in a relapsing pediatric patient with myelin oligodendrocyte glycoprotein antibody–associated disease manifesting as acute disseminated encephalomyelitis, unilateral optic neuritis, and seizure episodes

Corrigendum: Blood biomarker dynamics in people with relapsing multiple sclerosis treated with cladribine tablets: results of the 2-year MAGNIFY-MS study

Comparison of clinical and laboratory characteristics of neuromyelitis optica spectrum disorder with or without cerebrospinal fluid oligoclonal bands: a cohort with 36-month follow-up

Case Report: MOGAD - a steroid-responsive autoimmune meningoencephalitis mimicking infection

The changes of NLRs family members in the brain of AD mouse model and AD patients

CASPR2-Associated Autoimmune Encephalitis with NF155 Antibody-Positive Autoimmune Nodopathies: A Rare Case with Hyponatremia Onset

Unraveling the immune system’s role in peripheral nerve regeneration: a pathway to enhanced healing

Ofatumumab treatment for concomitant multiple sclerosis and idiopathic thrombocytopenic purpura

Super-resolution of nodal and paranodal disruption in anti-pan-neurofascin-associated autoimmune nodopathy

Case report: Plasma exchange as a therapy for Miller-Fisher syndrome

Artificial intelligence and science of patient input: a perspective from people with multiple sclerosis

Sexual dimorphism in immunity and longevity among the oldest old